Gelclair ® is the company's third commercialized prescription product Oral mucositis, also called "chemo mouth," a painful inflammation of the mouth's mucous membranes, has emerged as the most ...
This product represents the third prescription solution commercialized by Jaguar's family company, Napo Pharmaceuticals. Oral mucositis, often referred to as "chemo mouth," is a significant ...
The stock of small-cap biotech Jaguar Health Inc. rose 3% on Wednesday, after the company launched its gelclair treatment for oral mucositis, a common side effect suffered by head and neck cancer ...
This product represents the third prescription solution commercialized by Jaguar's family company, Napo Pharmaceuticals. Oral mucositis, often referred to as "chemo mouth," is a significant adverse ...